CytoVeris
Farmington, US · Founded 2018 · Delaware corporation
Founders & leadership
FK
F. Kevin DiddenNamed on SEC filing
MG
Michael GrilloNamed on SEC filing
MS
Michael SapackNamed on SEC filing
AD
Alan D KerseyNamed on SEC filing
PM
Patrick M. CurryNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$10M disclosed across 3 rounds · 2018–2021
▶$3.4MraisedNov 2021 · 1 investors · OtherRule 506(b)
▶$3.4MraisedNov 2021 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Alan D KerseyExecutive Officer, Director
- Scott FloraDirector
- Patrick M. CurryExecutive Officer
- Michael SapackExecutive Officer
- F. Kevin DiddenDirector
- Patrick O'NeillDirector
- Michael GrilloDirector
- Offering amount
- $10M
- Amount sold
- $3.4M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3.7MraisedApr 2020 · 5 investors · OtherRule 506(b)
▶$3.7MraisedApr 2020 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- F. Kevin DiddenDirector
- Alan D KerseyExecutive Officer, Director
- Michael SapackExecutive Officer
- Patrick M. CurryExecutive Officer
- Michael GrilloExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $3.7M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$2.9MraisedOct 2018 · 5 investors · OtherRule 506(b)
▶$2.9MraisedOct 2018 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- F. Kevin DiddenDirector
- Michael GrilloExecutive Officer, Director
- Michael SapackExecutive Officer
- Alan D KerseyExecutive Officer, Director
- Patrick M. CurryExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $2.9M
- First sale
- Sep 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $399.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has CytoVeris raised?
- CytoVeris has disclosed $10M raised across 3 rounds.
- Where is CytoVeris headquartered?
- CytoVeris is headquartered in Farmington, US.